Stephanie R. Earnshaw

Director/Miembro de la Junta en International Society for Pharmacoeconomics & Outcomes Rsch .

Commercial Services

Consumer Services

Perfil

Stephanie R.
Earnshaw is currently the Director at the International Society for Pharmacoeconomics & Outcomes Research.
She holds a graduate and doctorate degree from North Carolina State University.

Cargos activos de Stephanie R. Earnshaw

Empresas	Cargo	Inicio
International Society for Pharmacoeconomics & Outcomes Rsch International Society for Pharmacoeconomics & Outcomes Rsch Miscellaneous Commercial ServicesCommercial Services International Society for Pharmacoeconomics & Outcomes Research provides health care researches. The organization have health care researchers from all disciplines conducting health care outcomes research. These disciplines include pharmacoeconomics (health economics), epidemiology (pharmacoepidemiology), decision analysis, modeling, risk assessment, patient-reported outcomes (quality of life), use of ‘real world’ data such as health care database analyses, observational studies, patient registries.	Director/Miembro de la Junta	-

Todos los cargos activos de Stephanie R. Earnshaw

Formación de Stephanie R. Earnshaw.

North Carolina State University

Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Stephanie R. Earnshaw.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	1
International Society for Pharmacoeconomics & Outcomes Rsch International Society for Pharmacoeconomics & Outcomes Rsch Miscellaneous Commercial ServicesCommercial Services International Society for Pharmacoeconomics & Outcomes Research provides health care researches. The organization have health care researchers from all disciplines conducting health care outcomes research. These disciplines include pharmacoeconomics (health economics), epidemiology (pharmacoepidemiology), decision analysis, modeling, risk assessment, patient-reported outcomes (quality of life), use of ‘real world’ data such as health care database analyses, observational studies, patient registries.	Commercial Services